Global Recombinant Antibody Production Service Market 2024 by Company, Regions, Type and Application, Forecast to 2030
Page: 127
Published Date: 14 Jan 2024
Category: Service & Software
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
According to our (Global Info Research) latest study, the global Recombinant Antibody Production Service market size was valued at USD 837.6 million in 2023 and is forecast to a readjusted size of USD 1207.1 million by 2030 with a CAGR of 5.4% during review period.
The Global Info Research report includes an overview of the development of the Recombinant Antibody Production Service industry chain, the market status of Pharmaceutical (High-throughput Antibody Production Service, Small to Mid-scale Antibody Production Service), Biotechnology Company (High-throughput Antibody Production Service, Small to Mid-scale Antibody Production Service), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Recombinant Antibody Production Service.
Regionally, the report analyzes the Recombinant Antibody Production Service markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Recombinant Antibody Production Service market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Recombinant Antibody Production Service market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Recombinant Antibody Production Service industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., High-throughput Antibody Production Service, Small to Mid-scale Antibody Production Service).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Recombinant Antibody Production Service market.
Regional Analysis: The report involves examining the Recombinant Antibody Production Service market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Recombinant Antibody Production Service market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Recombinant Antibody Production Service:
Company Analysis: Report covers individual Recombinant Antibody Production Service players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Recombinant Antibody Production Service This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Pharmaceutical, Biotechnology Company).
Technology Analysis: Report covers specific technologies relevant to Recombinant Antibody Production Service. It assesses the current state, advancements, and potential future developments in Recombinant Antibody Production Service areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Recombinant Antibody Production Service market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Recombinant Antibody Production Service market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
High-throughput Antibody Production Service
Small to Mid-scale Antibody Production Service
Large-scale Antibody Production Service
Chimeric Antibody Production Service
Antibody Fragment Production Service
Bispecific Antibody Production Service
Others
Market segment by Application
Pharmaceutical
Biotechnology Company
Others
Market segment by players, this report covers
evitria SA
Bon Opus Biosciences
Biomatik
Biointron Biological Inc.
Sino Biological
ProSci Inc
GenScript
RayBiotech
Cygnus Technologies
Cusabio Technology
Absolute Antibody
Cayman Chemical
Creative Biolabs
Promab Biotechnologies
Leinco Technologies
R&D Systems
Rapid Novor
ACROBiosystems
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Recombinant Antibody Production Service product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Recombinant Antibody Production Service, with revenue, gross margin and global market share of Recombinant Antibody Production Service from 2019 to 2024.
Chapter 3, the Recombinant Antibody Production Service competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Recombinant Antibody Production Service market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Recombinant Antibody Production Service.
Chapter 13, to describe Recombinant Antibody Production Service research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Recombinant Antibody Production Service
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Recombinant Antibody Production Service by Type
1.3.1 Overview: Global Recombinant Antibody Production Service Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Recombinant Antibody Production Service Consumption Value Market Share by Type in 2023
1.3.3 High-throughput Antibody Production Service
1.3.4 Small to Mid-scale Antibody Production Service
1.3.5 Large-scale Antibody Production Service
1.3.6 Chimeric Antibody Production Service
1.3.7 Antibody Fragment Production Service
1.3.8 Bispecific Antibody Production Service
1.3.9 Others
1.4 Global Recombinant Antibody Production Service Market by Application
1.4.1 Overview: Global Recombinant Antibody Production Service Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Pharmaceutical
1.4.3 Biotechnology Company
1.4.4 Others
1.5 Global Recombinant Antibody Production Service Market Size & Forecast
1.6 Global Recombinant Antibody Production Service Market Size and Forecast by Region
1.6.1 Global Recombinant Antibody Production Service Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Recombinant Antibody Production Service Market Size by Region, (2019-2030)
1.6.3 North America Recombinant Antibody Production Service Market Size and Prospect (2019-2030)
1.6.4 Europe Recombinant Antibody Production Service Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Recombinant Antibody Production Service Market Size and Prospect (2019-2030)
1.6.6 South America Recombinant Antibody Production Service Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Recombinant Antibody Production Service Market Size and Prospect (2019-2030)
2.1 evitria SA
2.1.1 evitria SA Details
2.1.2 evitria SA Major Business
2.1.3 evitria SA Recombinant Antibody Production Service Product and Solutions
2.1.4 evitria SA Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 evitria SA Recent Developments and Future Plans
2.2 Bon Opus Biosciences
2.2.1 Bon Opus Biosciences Details
2.2.2 Bon Opus Biosciences Major Business
2.2.3 Bon Opus Biosciences Recombinant Antibody Production Service Product and Solutions
2.2.4 Bon Opus Biosciences Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Bon Opus Biosciences Recent Developments and Future Plans
2.3 Biomatik
2.3.1 Biomatik Details
2.3.2 Biomatik Major Business
2.3.3 Biomatik Recombinant Antibody Production Service Product and Solutions
2.3.4 Biomatik Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Biomatik Recent Developments and Future Plans
2.4 Biointron Biological Inc.
2.4.1 Biointron Biological Inc. Details
2.4.2 Biointron Biological Inc. Major Business
2.4.3 Biointron Biological Inc. Recombinant Antibody Production Service Product and Solutions
2.4.4 Biointron Biological Inc. Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Biointron Biological Inc. Recent Developments and Future Plans
2.5 Sino Biological
2.5.1 Sino Biological Details
2.5.2 Sino Biological Major Business
2.5.3 Sino Biological Recombinant Antibody Production Service Product and Solutions
2.5.4 Sino Biological Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Sino Biological Recent Developments and Future Plans
2.6 ProSci Inc
2.6.1 ProSci Inc Details
2.6.2 ProSci Inc Major Business
2.6.3 ProSci Inc Recombinant Antibody Production Service Product and Solutions
2.6.4 ProSci Inc Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 ProSci Inc Recent Developments and Future Plans
2.7 GenScript
2.7.1 GenScript Details
2.7.2 GenScript Major Business
2.7.3 GenScript Recombinant Antibody Production Service Product and Solutions
2.7.4 GenScript Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 GenScript Recent Developments and Future Plans
2.8 RayBiotech
2.8.1 RayBiotech Details
2.8.2 RayBiotech Major Business
2.8.3 RayBiotech Recombinant Antibody Production Service Product and Solutions
2.8.4 RayBiotech Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 RayBiotech Recent Developments and Future Plans
2.9 Cygnus Technologies
2.9.1 Cygnus Technologies Details
2.9.2 Cygnus Technologies Major Business
2.9.3 Cygnus Technologies Recombinant Antibody Production Service Product and Solutions
2.9.4 Cygnus Technologies Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Cygnus Technologies Recent Developments and Future Plans
2.10 Cusabio Technology
2.10.1 Cusabio Technology Details
2.10.2 Cusabio Technology Major Business
2.10.3 Cusabio Technology Recombinant Antibody Production Service Product and Solutions
2.10.4 Cusabio Technology Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Cusabio Technology Recent Developments and Future Plans
2.11 Absolute Antibody
2.11.1 Absolute Antibody Details
2.11.2 Absolute Antibody Major Business
2.11.3 Absolute Antibody Recombinant Antibody Production Service Product and Solutions
2.11.4 Absolute Antibody Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Absolute Antibody Recent Developments and Future Plans
2.12 Cayman Chemical
2.12.1 Cayman Chemical Details
2.12.2 Cayman Chemical Major Business
2.12.3 Cayman Chemical Recombinant Antibody Production Service Product and Solutions
2.12.4 Cayman Chemical Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Cayman Chemical Recent Developments and Future Plans
2.13 Creative Biolabs
2.13.1 Creative Biolabs Details
2.13.2 Creative Biolabs Major Business
2.13.3 Creative Biolabs Recombinant Antibody Production Service Product and Solutions
2.13.4 Creative Biolabs Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Creative Biolabs Recent Developments and Future Plans
2.14 Promab Biotechnologies
2.14.1 Promab Biotechnologies Details
2.14.2 Promab Biotechnologies Major Business
2.14.3 Promab Biotechnologies Recombinant Antibody Production Service Product and Solutions
2.14.4 Promab Biotechnologies Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Promab Biotechnologies Recent Developments and Future Plans
2.15 Leinco Technologies
2.15.1 Leinco Technologies Details
2.15.2 Leinco Technologies Major Business
2.15.3 Leinco Technologies Recombinant Antibody Production Service Product and Solutions
2.15.4 Leinco Technologies Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Leinco Technologies Recent Developments and Future Plans
2.16 R&D Systems
2.16.1 R&D Systems Details
2.16.2 R&D Systems Major Business
2.16.3 R&D Systems Recombinant Antibody Production Service Product and Solutions
2.16.4 R&D Systems Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 R&D Systems Recent Developments and Future Plans
2.17 Rapid Novor
2.17.1 Rapid Novor Details
2.17.2 Rapid Novor Major Business
2.17.3 Rapid Novor Recombinant Antibody Production Service Product and Solutions
2.17.4 Rapid Novor Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 Rapid Novor Recent Developments and Future Plans
2.18 ACROBiosystems
2.18.1 ACROBiosystems Details
2.18.2 ACROBiosystems Major Business
2.18.3 ACROBiosystems Recombinant Antibody Production Service Product and Solutions
2.18.4 ACROBiosystems Recombinant Antibody Production Service Revenue, Gross Margin and Market Share (2019-2024)
2.18.5 ACROBiosystems Recent Developments and Future Plans
3.1 Global Recombinant Antibody Production Service Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Recombinant Antibody Production Service by Company Revenue
3.2.2 Top 3 Recombinant Antibody Production Service Players Market Share in 2023
3.2.3 Top 6 Recombinant Antibody Production Service Players Market Share in 2023
3.3 Recombinant Antibody Production Service Market: Overall Company Footprint Analysis
3.3.1 Recombinant Antibody Production Service Market: Region Footprint
3.3.2 Recombinant Antibody Production Service Market: Company Product Type Footprint
3.3.3 Recombinant Antibody Production Service Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global Recombinant Antibody Production Service Consumption Value and Market Share by Type (2019-2024)
4.2 Global Recombinant Antibody Production Service Market Forecast by Type (2025-2030)
5.1 Global Recombinant Antibody Production Service Consumption Value Market Share by Application (2019-2024)
5.2 Global Recombinant Antibody Production Service Market Forecast by Application (2025-2030)
6.1 North America Recombinant Antibody Production Service Consumption Value by Type (2019-2030)
6.2 North America Recombinant Antibody Production Service Consumption Value by Application (2019-2030)
6.3 North America Recombinant Antibody Production Service Market Size by Country
6.3.1 North America Recombinant Antibody Production Service Consumption Value by Country (2019-2030)
6.3.2 United States Recombinant Antibody Production Service Market Size and Forecast (2019-2030)
6.3.3 Canada Recombinant Antibody Production Service Market Size and Forecast (2019-2030)
6.3.4 Mexico Recombinant Antibody Production Service Market Size and Forecast (2019-2030)
7.1 Europe Recombinant Antibody Production Service Consumption Value by Type (2019-2030)
7.2 Europe Recombinant Antibody Production Service Consumption Value by Application (2019-2030)
7.3 Europe Recombinant Antibody Production Service Market Size by Country
7.3.1 Europe Recombinant Antibody Production Service Consumption Value by Country (2019-2030)
7.3.2 Germany Recombinant Antibody Production Service Market Size and Forecast (2019-2030)
7.3.3 France Recombinant Antibody Production Service Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Recombinant Antibody Production Service Market Size and Forecast (2019-2030)
7.3.5 Russia Recombinant Antibody Production Service Market Size and Forecast (2019-2030)
7.3.6 Italy Recombinant Antibody Production Service Market Size and Forecast (2019-2030)
8.1 Asia-Pacific Recombinant Antibody Production Service Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Recombinant Antibody Production Service Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Recombinant Antibody Production Service Market Size by Region
8.3.1 Asia-Pacific Recombinant Antibody Production Service Consumption Value by Region (2019-2030)
8.3.2 China Recombinant Antibody Production Service Market Size and Forecast (2019-2030)
8.3.3 Japan Recombinant Antibody Production Service Market Size and Forecast (2019-2030)
8.3.4 South Korea Recombinant Antibody Production Service Market Size and Forecast (2019-2030)
8.3.5 India Recombinant Antibody Production Service Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Recombinant Antibody Production Service Market Size and Forecast (2019-2030)
8.3.7 Australia Recombinant Antibody Production Service Market Size and Forecast (2019-2030)
9.1 South America Recombinant Antibody Production Service Consumption Value by Type (2019-2030)
9.2 South America Recombinant Antibody Production Service Consumption Value by Application (2019-2030)
9.3 South America Recombinant Antibody Production Service Market Size by Country
9.3.1 South America Recombinant Antibody Production Service Consumption Value by Country (2019-2030)
9.3.2 Brazil Recombinant Antibody Production Service Market Size and Forecast (2019-2030)
9.3.3 Argentina Recombinant Antibody Production Service Market Size and Forecast (2019-2030)
10.1 Middle East & Africa Recombinant Antibody Production Service Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Recombinant Antibody Production Service Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Recombinant Antibody Production Service Market Size by Country
10.3.1 Middle East & Africa Recombinant Antibody Production Service Consumption Value by Country (2019-2030)
10.3.2 Turkey Recombinant Antibody Production Service Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Recombinant Antibody Production Service Market Size and Forecast (2019-2030)
10.3.4 UAE Recombinant Antibody Production Service Market Size and Forecast (2019-2030)
11.1 Recombinant Antibody Production Service Market Drivers
11.2 Recombinant Antibody Production Service Market Restraints
11.3 Recombinant Antibody Production Service Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12.1 Recombinant Antibody Production Service Industry Chain
12.2 Recombinant Antibody Production Service Upstream Analysis
12.3 Recombinant Antibody Production Service Midstream Analysis
12.4 Recombinant Antibody Production Service Downstream Analysis
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Recombinant Antibody Production Service Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Recombinant Antibody Production Service Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Recombinant Antibody Production Service Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Recombinant Antibody Production Service Consumption Value by Region (2025-2030) & (USD Million)
Table 5. evitria SA Company Information, Head Office, and Major Competitors
Table 6. evitria SA Major Business
Table 7. evitria SA Recombinant Antibody Production Service Product and Solutions
Table 8. evitria SA Recombinant Antibody Production Service Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. evitria SA Recent Developments and Future Plans
Table 10. Bon Opus Biosciences Company Information, Head Office, and Major Competitors
Table 11. Bon Opus Biosciences Major Business
Table 12. Bon Opus Biosciences Recombinant Antibody Production Service Product and Solutions
Table 13. Bon Opus Biosciences Recombinant Antibody Production Service Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Bon Opus Biosciences Recent Developments and Future Plans
Table 15. Biomatik Company Information, Head Office, and Major Competitors
Table 16. Biomatik Major Business
Table 17. Biomatik Recombinant Antibody Production Service Product and Solutions
Table 18. Biomatik Recombinant Antibody Production Service Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Biomatik Recent Developments and Future Plans
Table 20. Biointron Biological Inc. Company Information, Head Office, and Major Competitors
Table 21. Biointron Biological Inc. Major Business
Table 22. Biointron Biological Inc. Recombinant Antibody Production Service Product and Solutions
Table 23. Biointron Biological Inc. Recombinant Antibody Production Service Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Biointron Biological Inc. Recent Developments and Future Plans
Table 25. Sino Biological Company Information, Head Office, and Major Competitors
Table 26. Sino Biological Major Business
Table 27. Sino Biological Recombinant Antibody Production Service Product and Solutions
Table 28. Sino Biological Recombinant Antibody Production Service Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Sino Biological Recent Developments and Future Plans
Table 30. ProSci Inc Company Information, Head Office, and Major Competitors
Table 31. ProSci Inc Major Business
Table 32. ProSci Inc Recombinant Antibody Production Service Product and Solutions
Table 33. ProSci Inc Recombinant Antibody Production Service Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. ProSci Inc Recent Developments and Future Plans
Table 35. GenScript Company Information, Head Office, and Major Competitors
Table 36. GenScript Major Business
Table 37. GenScript Recombinant Antibody Production Service Product and Solutions
Table 38. GenScript Recombinant Antibody Production Service Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. GenScript Recent Developments and Future Plans
Table 40. RayBiotech Company Information, Head Office, and Major Competitors
Table 41. RayBiotech Major Business
Table 42. RayBiotech Recombinant Antibody Production Service Product and Solutions
Table 43. RayBiotech Recombinant Antibody Production Service Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. RayBiotech Recent Developments and Future Plans
Table 45. Cygnus Technologies Company Information, Head Office, and Major Competitors
Table 46. Cygnus Technologies Major Business
Table 47. Cygnus Technologies Recombinant Antibody Production Service Product and Solutions
Table 48. Cygnus Technologies Recombinant Antibody Production Service Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Cygnus Technologies Recent Developments and Future Plans
Table 50. Cusabio Technology Company Information, Head Office, and Major Competitors
Table 51. Cusabio Technology Major Business
Table 52. Cusabio Technology Recombinant Antibody Production Service Product and Solutions
Table 53. Cusabio Technology Recombinant Antibody Production Service Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Cusabio Technology Recent Developments and Future Plans
Table 55. Absolute Antibody Company Information, Head Office, and Major Competitors
Table 56. Absolute Antibody Major Business
Table 57. Absolute Antibody Recombinant Antibody Production Service Product and Solutions
Table 58. Absolute Antibody Recombinant Antibody Production Service Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Absolute Antibody Recent Developments and Future Plans
Table 60. Cayman Chemical Company Information, Head Office, and Major Competitors
Table 61. Cayman Chemical Major Business
Table 62. Cayman Chemical Recombinant Antibody Production Service Product and Solutions
Table 63. Cayman Chemical Recombinant Antibody Production Service Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. Cayman Chemical Recent Developments and Future Plans
Table 65. Creative Biolabs Company Information, Head Office, and Major Competitors
Table 66. Creative Biolabs Major Business
Table 67. Creative Biolabs Recombinant Antibody Production Service Product and Solutions
Table 68. Creative Biolabs Recombinant Antibody Production Service Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. Creative Biolabs Recent Developments and Future Plans
Table 70. Promab Biotechnologies Company Information, Head Office, and Major Competitors
Table 71. Promab Biotechnologies Major Business
Table 72. Promab Biotechnologies Recombinant Antibody Production Service Product and Solutions
Table 73. Promab Biotechnologies Recombinant Antibody Production Service Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 74. Promab Biotechnologies Recent Developments and Future Plans
Table 75. Leinco Technologies Company Information, Head Office, and Major Competitors
Table 76. Leinco Technologies Major Business
Table 77. Leinco Technologies Recombinant Antibody Production Service Product and Solutions
Table 78. Leinco Technologies Recombinant Antibody Production Service Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 79. Leinco Technologies Recent Developments and Future Plans
Table 80. R&D Systems Company Information, Head Office, and Major Competitors
Table 81. R&D Systems Major Business
Table 82. R&D Systems Recombinant Antibody Production Service Product and Solutions
Table 83. R&D Systems Recombinant Antibody Production Service Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 84. R&D Systems Recent Developments and Future Plans
Table 85. Rapid Novor Company Information, Head Office, and Major Competitors
Table 86. Rapid Novor Major Business
Table 87. Rapid Novor Recombinant Antibody Production Service Product and Solutions
Table 88. Rapid Novor Recombinant Antibody Production Service Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Rapid Novor Recent Developments and Future Plans
Table 90. ACROBiosystems Company Information, Head Office, and Major Competitors
Table 91. ACROBiosystems Major Business
Table 92. ACROBiosystems Recombinant Antibody Production Service Product and Solutions
Table 93. ACROBiosystems Recombinant Antibody Production Service Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 94. ACROBiosystems Recent Developments and Future Plans
Table 95. Global Recombinant Antibody Production Service Revenue (USD Million) by Players (2019-2024)
Table 96. Global Recombinant Antibody Production Service Revenue Share by Players (2019-2024)
Table 97. Breakdown of Recombinant Antibody Production Service by Company Type (Tier 1, Tier 2, and Tier 3)
Table 98. Market Position of Players in Recombinant Antibody Production Service, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 99. Head Office of Key Recombinant Antibody Production Service Players
Table 100. Recombinant Antibody Production Service Market: Company Product Type Footprint
Table 101. Recombinant Antibody Production Service Market: Company Product Application Footprint
Table 102. Recombinant Antibody Production Service New Market Entrants and Barriers to Market Entry
Table 103. Recombinant Antibody Production Service Mergers, Acquisition, Agreements, and Collaborations
Table 104. Global Recombinant Antibody Production Service Consumption Value (USD Million) by Type (2019-2024)
Table 105. Global Recombinant Antibody Production Service Consumption Value Share by Type (2019-2024)
Table 106. Global Recombinant Antibody Production Service Consumption Value Forecast by Type (2025-2030)
Table 107. Global Recombinant Antibody Production Service Consumption Value by Application (2019-2024)
Table 108. Global Recombinant Antibody Production Service Consumption Value Forecast by Application (2025-2030)
Table 109. North America Recombinant Antibody Production Service Consumption Value by Type (2019-2024) & (USD Million)
Table 110. North America Recombinant Antibody Production Service Consumption Value by Type (2025-2030) & (USD Million)
Table 111. North America Recombinant Antibody Production Service Consumption Value by Application (2019-2024) & (USD Million)
Table 112. North America Recombinant Antibody Production Service Consumption Value by Application (2025-2030) & (USD Million)
Table 113. North America Recombinant Antibody Production Service Consumption Value by Country (2019-2024) & (USD Million)
Table 114. North America Recombinant Antibody Production Service Consumption Value by Country (2025-2030) & (USD Million)
Table 115. Europe Recombinant Antibody Production Service Consumption Value by Type (2019-2024) & (USD Million)
Table 116. Europe Recombinant Antibody Production Service Consumption Value by Type (2025-2030) & (USD Million)
Table 117. Europe Recombinant Antibody Production Service Consumption Value by Application (2019-2024) & (USD Million)
Table 118. Europe Recombinant Antibody Production Service Consumption Value by Application (2025-2030) & (USD Million)
Table 119. Europe Recombinant Antibody Production Service Consumption Value by Country (2019-2024) & (USD Million)
Table 120. Europe Recombinant Antibody Production Service Consumption Value by Country (2025-2030) & (USD Million)
Table 121. Asia-Pacific Recombinant Antibody Production Service Consumption Value by Type (2019-2024) & (USD Million)
Table 122. Asia-Pacific Recombinant Antibody Production Service Consumption Value by Type (2025-2030) & (USD Million)
Table 123. Asia-Pacific Recombinant Antibody Production Service Consumption Value by Application (2019-2024) & (USD Million)
Table 124. Asia-Pacific Recombinant Antibody Production Service Consumption Value by Application (2025-2030) & (USD Million)
Table 125. Asia-Pacific Recombinant Antibody Production Service Consumption Value by Region (2019-2024) & (USD Million)
Table 126. Asia-Pacific Recombinant Antibody Production Service Consumption Value by Region (2025-2030) & (USD Million)
Table 127. South America Recombinant Antibody Production Service Consumption Value by Type (2019-2024) & (USD Million)
Table 128. South America Recombinant Antibody Production Service Consumption Value by Type (2025-2030) & (USD Million)
Table 129. South America Recombinant Antibody Production Service Consumption Value by Application (2019-2024) & (USD Million)
Table 130. South America Recombinant Antibody Production Service Consumption Value by Application (2025-2030) & (USD Million)
Table 131. South America Recombinant Antibody Production Service Consumption Value by Country (2019-2024) & (USD Million)
Table 132. South America Recombinant Antibody Production Service Consumption Value by Country (2025-2030) & (USD Million)
Table 133. Middle East & Africa Recombinant Antibody Production Service Consumption Value by Type (2019-2024) & (USD Million)
Table 134. Middle East & Africa Recombinant Antibody Production Service Consumption Value by Type (2025-2030) & (USD Million)
Table 135. Middle East & Africa Recombinant Antibody Production Service Consumption Value by Application (2019-2024) & (USD Million)
Table 136. Middle East & Africa Recombinant Antibody Production Service Consumption Value by Application (2025-2030) & (USD Million)
Table 137. Middle East & Africa Recombinant Antibody Production Service Consumption Value by Country (2019-2024) & (USD Million)
Table 138. Middle East & Africa Recombinant Antibody Production Service Consumption Value by Country (2025-2030) & (USD Million)
Table 139. Recombinant Antibody Production Service Raw Material
Table 140. Key Suppliers of Recombinant Antibody Production Service Raw Materials
List of Figures
Figure 1. Recombinant Antibody Production Service Picture
Figure 2. Global Recombinant Antibody Production Service Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Recombinant Antibody Production Service Consumption Value Market Share by Type in 2023
Figure 4. High-throughput Antibody Production Service
Figure 5. Small to Mid-scale Antibody Production Service
Figure 6. Large-scale Antibody Production Service
Figure 7. Chimeric Antibody Production Service
Figure 8. Antibody Fragment Production Service
Figure 9. Bispecific Antibody Production Service
Figure 10. Others
Figure 11. Global Recombinant Antibody Production Service Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 12. Recombinant Antibody Production Service Consumption Value Market Share by Application in 2023
Figure 13. Pharmaceutical Picture
Figure 14. Biotechnology Company Picture
Figure 15. Others Picture
Figure 16. Global Recombinant Antibody Production Service Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 17. Global Recombinant Antibody Production Service Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 18. Global Market Recombinant Antibody Production Service Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 19. Global Recombinant Antibody Production Service Consumption Value Market Share by Region (2019-2030)
Figure 20. Global Recombinant Antibody Production Service Consumption Value Market Share by Region in 2023
Figure 21. North America Recombinant Antibody Production Service Consumption Value (2019-2030) & (USD Million)
Figure 22. Europe Recombinant Antibody Production Service Consumption Value (2019-2030) & (USD Million)
Figure 23. Asia-Pacific Recombinant Antibody Production Service Consumption Value (2019-2030) & (USD Million)
Figure 24. South America Recombinant Antibody Production Service Consumption Value (2019-2030) & (USD Million)
Figure 25. Middle East and Africa Recombinant Antibody Production Service Consumption Value (2019-2030) & (USD Million)
Figure 26. Global Recombinant Antibody Production Service Revenue Share by Players in 2023
Figure 27. Recombinant Antibody Production Service Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 28. Global Top 3 Players Recombinant Antibody Production Service Market Share in 2023
Figure 29. Global Top 6 Players Recombinant Antibody Production Service Market Share in 2023
Figure 30. Global Recombinant Antibody Production Service Consumption Value Share by Type (2019-2024)
Figure 31. Global Recombinant Antibody Production Service Market Share Forecast by Type (2025-2030)
Figure 32. Global Recombinant Antibody Production Service Consumption Value Share by Application (2019-2024)
Figure 33. Global Recombinant Antibody Production Service Market Share Forecast by Application (2025-2030)
Figure 34. North America Recombinant Antibody Production Service Consumption Value Market Share by Type (2019-2030)
Figure 35. North America Recombinant Antibody Production Service Consumption Value Market Share by Application (2019-2030)
Figure 36. North America Recombinant Antibody Production Service Consumption Value Market Share by Country (2019-2030)
Figure 37. United States Recombinant Antibody Production Service Consumption Value (2019-2030) & (USD Million)
Figure 38. Canada Recombinant Antibody Production Service Consumption Value (2019-2030) & (USD Million)
Figure 39. Mexico Recombinant Antibody Production Service Consumption Value (2019-2030) & (USD Million)
Figure 40. Europe Recombinant Antibody Production Service Consumption Value Market Share by Type (2019-2030)
Figure 41. Europe Recombinant Antibody Production Service Consumption Value Market Share by Application (2019-2030)
Figure 42. Europe Recombinant Antibody Production Service Consumption Value Market Share by Country (2019-2030)
Figure 43. Germany Recombinant Antibody Production Service Consumption Value (2019-2030) & (USD Million)
Figure 44. France Recombinant Antibody Production Service Consumption Value (2019-2030) & (USD Million)
Figure 45. United Kingdom Recombinant Antibody Production Service Consumption Value (2019-2030) & (USD Million)
Figure 46. Russia Recombinant Antibody Production Service Consumption Value (2019-2030) & (USD Million)
Figure 47. Italy Recombinant Antibody Production Service Consumption Value (2019-2030) & (USD Million)
Figure 48. Asia-Pacific Recombinant Antibody Production Service Consumption Value Market Share by Type (2019-2030)
Figure 49. Asia-Pacific Recombinant Antibody Production Service Consumption Value Market Share by Application (2019-2030)
Figure 50. Asia-Pacific Recombinant Antibody Production Service Consumption Value Market Share by Region (2019-2030)
Figure 51. China Recombinant Antibody Production Service Consumption Value (2019-2030) & (USD Million)
Figure 52. Japan Recombinant Antibody Production Service Consumption Value (2019-2030) & (USD Million)
Figure 53. South Korea Recombinant Antibody Production Service Consumption Value (2019-2030) & (USD Million)
Figure 54. India Recombinant Antibody Production Service Consumption Value (2019-2030) & (USD Million)
Figure 55. Southeast Asia Recombinant Antibody Production Service Consumption Value (2019-2030) & (USD Million)
Figure 56. Australia Recombinant Antibody Production Service Consumption Value (2019-2030) & (USD Million)
Figure 57. South America Recombinant Antibody Production Service Consumption Value Market Share by Type (2019-2030)
Figure 58. South America Recombinant Antibody Production Service Consumption Value Market Share by Application (2019-2030)
Figure 59. South America Recombinant Antibody Production Service Consumption Value Market Share by Country (2019-2030)
Figure 60. Brazil Recombinant Antibody Production Service Consumption Value (2019-2030) & (USD Million)
Figure 61. Argentina Recombinant Antibody Production Service Consumption Value (2019-2030) & (USD Million)
Figure 62. Middle East and Africa Recombinant Antibody Production Service Consumption Value Market Share by Type (2019-2030)
Figure 63. Middle East and Africa Recombinant Antibody Production Service Consumption Value Market Share by Application (2019-2030)
Figure 64. Middle East and Africa Recombinant Antibody Production Service Consumption Value Market Share by Country (2019-2030)
Figure 65. Turkey Recombinant Antibody Production Service Consumption Value (2019-2030) & (USD Million)
Figure 66. Saudi Arabia Recombinant Antibody Production Service Consumption Value (2019-2030) & (USD Million)
Figure 67. UAE Recombinant Antibody Production Service Consumption Value (2019-2030) & (USD Million)
Figure 68. Recombinant Antibody Production Service Market Drivers
Figure 69. Recombinant Antibody Production Service Market Restraints
Figure 70. Recombinant Antibody Production Service Market Trends
Figure 71. Porters Five Forces Analysis
Figure 72. Manufacturing Cost Structure Analysis of Recombinant Antibody Production Service in 2023
Figure 73. Manufacturing Process Analysis of Recombinant Antibody Production Service
Figure 74. Recombinant Antibody Production Service Industrial Chain
Figure 75. Methodology
Figure 76. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
evitria SA Bon Opus Biosciences Biomatik Biointron Biological Inc. Sino Biological ProSci Inc GenScript RayBiotech Cygnus Technologies Cusabio Technology Absolute Antibody Cayman Chemical Creative Biolabs Promab Biotechnologies Leinco Technologies R&D Systems Rapid Novor ACROBiosystems
Related Reports
26 Jul 2023
Service & Software
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
